Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
12,683
datasets available to search
ShareScore release 0.9.0
Dataset results
12,683 results for “tolerability”
Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease
ClinicalTrials.gov study NCT02925650. IPD Sharing: YES. Countries: 1. Publications: 2.
Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults
ClinicalTrials.gov study NCT05118386. IPD Sharing: YES. Countries: 1. Publications: 3.
Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis
ClinicalTrials.gov study NCT04181762. IPD Sharing: YES. Countries: 34. Publications: 2.
16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis
ClinicalTrials.gov study NCT01649375. IPD Sharing: UNDECIDED. Countries: 13. Publications: 14.
Extension in AS: Sustainability of Benefits, Safety and Tolerability
ClinicalTrials.gov study NCT01863732. IPD Sharing: UNDECIDED. Countries: 14. Publications: 5.
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
ClinicalTrials.gov study NCT01386658. IPD Sharing: YES. Countries: 10. Publications: 1.
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Fai
ClinicalTrials.gov study NCT02678312. IPD Sharing: YES. Countries: 29. Publications: 2.
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov study NCT01201356. IPD Sharing: YES. Countries: 38. Publications: 1.
Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis
ClinicalTrials.gov study NCT03517540. IPD Sharing: UNDECIDED. Countries: 17. Publications: 2.
Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy
ClinicalTrials.gov study NCT03344640. IPD Sharing: UNDECIDED. Countries: 5. Publications: 0.
Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis
ClinicalTrials.gov study NCT02404350. IPD Sharing: UNDECIDED. Countries: 28. Publications: 6.
Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder
ClinicalTrials.gov study NCT02466386. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects
ClinicalTrials.gov study NCT01677741. IPD Sharing: YES. Countries: 10. Publications: 4.
Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
ClinicalTrials.gov study NCT03439839. IPD Sharing: YES. Countries: 3. Publications: 1.
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients
ClinicalTrials.gov study NCT03623243. IPD Sharing: YES. Countries: 2. Publications: 1.
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With
ClinicalTrials.gov study NCT03650452. IPD Sharing: YES. Countries: 8. Publications: 1.
Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
ClinicalTrials.gov study NCT03327402. IPD Sharing: YES. Countries: 1. Publications: 1.
An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU
ClinicalTrials.gov study NCT04109313. IPD Sharing: YES. Countries: 15. Publications: 1.
Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis
ClinicalTrials.gov study NCT04864392. IPD Sharing: YES. Countries: 15. Publications: 1.
A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)
ClinicalTrials.gov study NCT04988087. IPD Sharing: YES. Countries: 6. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.